• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Astrana Health, Inc. Announces Share Repurchase of 300,000 Shares

    1/21/25 7:45:00 AM ET
    $ASTH
    Professional Services
    Consumer Discretionary
    Get the next $ASTH alert in real time by email

    ALHAMBRA, Calif., Jan. 21, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that on January 17, 2025, the Company repurchased 300,000 shares of the Company's common stock for the aggregate purchase price of $10.551 million, based on a purchase price per share of $35.17, which was the closing price per share on the Nasdaq Stock Market on such date.

    Astrana Health Logo (PRNewsfoto/Astrana Health, Inc.)

    "The share repurchase is a testament to management and the Board of Directors' confidence in the performance of Astrana Health. We remain committed to our strategic capital deployment practices and continue to prioritize long-term growth, including through opportunistic share repurchases," said Brandon K. Sim, President and CEO of Astrana.

    The shares were purchased from Allied Physicians of California, a Professional Medical Corporation ("APC"), a long-standing stockholder and a consolidated affiliate of the Company. The Company's Board of Directors and the Audit Committee of the Board of Directors approved the repurchase.

    About Astrana Health, Inc.

    Astrana is a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all. Leveraging its proprietary end-to-end technology solutions, Astrana operates an integrated healthcare delivery platform that enables providers to successfully participate in value-based care arrangements, thus empowering them to deliver high quality care to patients in a cost-effective manner.

    Headquartered in Alhambra, California, Astrana serves over 12,000 providers and over 1.1 million Americans in value-based care arrangements. Its subsidiaries and affiliates include management services organizations (MSOs), affiliated independent practice associations (IPAs), accountable care organizations (ACOs), and care delivery entities across primary, multi-specialty, and ancillary care. For more information, please visit www.astranahealth.com.

    FOR MORE INFORMATION, PLEASE CONTACT:

    Investor Relations

    (626) 943-6491

    Asher Dewhurst

    [email protected]

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/astrana-health-inc-announces-share-repurchase-of-300-000-shares-302356096.html

    SOURCE Astrana Health, Inc.

    Get the next $ASTH alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $ASTH

    DatePrice TargetRatingAnalyst
    4/1/2025$36.00Equal Weight
    Barclays
    10/14/2024$66.00Buy
    TD Cowen
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    7/11/2024$44.00 → $50.00Hold → Buy
    Truist
    5/30/2024$54.00Outperform
    Robert W. Baird
    More analyst ratings

    $ASTH
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • Astrana Health Strengthens Leadership Team to Scale AI-Enabled Healthcare Delivery Platform for All

      ALHAMBRA, Calif., June 3, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a physician-centric, technology-enabled healthcare company empowering providers to deliver accessible, high-quality, and high-value care to all, today announced several key additions to its senior leadership team. These appointments reinforce the company's commitment to scaling its AI-enabled, value-based care platform and driving growth across its expanding national footprint. Sherry McBride has joined Astran

      6/3/25 8:00:00 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. to Participate in Upcoming Investor Conference

      ALHAMBRA, Calif., June 2, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that Brandon Sim, President and CEO is participating in the William Blair 2025 Growth Stock Conference, being held in Chicago, from Tuesday, June 3, 2025 to Thursday June 5, 2025 including a presentation at 10:40 am CT on Wednesday, June 4. The we

      6/2/25 4:56:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. Reports First Quarter 2025 Results

      Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., May 8, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2025. "Astrana's strong start to the year reflects the continued momentum behind our mis

      5/8/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • COO and CFO Basho Chandan covered exercise/tax liability with 10,035 shares, decreasing direct ownership by 5% to 178,640 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      5/19/25 6:12:01 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Chief Medical Officer Kumar Dinesh M. covered exercise/tax liability with 828 shares, decreasing direct ownership by 0.36% to 227,298 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      4/30/25 8:44:02 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • COO and CFO Basho Chandan covered exercise/tax liability with 2,683 shares, decreasing direct ownership by 1% to 188,675 units (SEC Form 4)

      4 - Astrana Health, Inc. (0001083446) (Issuer)

      4/16/25 4:15:20 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    SEC Filings

    See more
    • Astrana Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      5/13/25 4:15:50 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • SEC Form 10-Q filed by Astrana Health Inc.

      10-Q - Astrana Health, Inc. (0001083446) (Filer)

      5/9/25 5:02:17 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

      8-K - Astrana Health, Inc. (0001083446) (Filer)

      5/8/25 4:15:57 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    Financials

    Live finance-specific insights

    See more
    • Astrana Health, Inc. Reports First Quarter 2025 Results

      Company to Host Conference Call on Thursday, May 8, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., May 8, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the first quarter ended March 31, 2025. "Astrana's strong start to the year reflects the continued momentum behind our mis

      5/8/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. Schedules 2025 First Quarter Financial Results Release and Conference Call

      ALHAMBRA, Calif., April 15, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced that it will release financial results for the first quarter ended March 31, 2025, after the close of the stock market on Thursday, May 8, 2025. The Company will discuss those results on a conference call at 2:30 p.m. PT/5:30 p.m. ET that same day.

      4/15/25 4:05:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • Astrana Health, Inc. Reports Fourth Quarter and Year-End 2024 Results

      Company to Host Conference Call on Thursday, February 27, 2025, at 2:30 p.m. PT/5:30 p.m. ET ALHAMBRA, Calif., Feb. 27, 2025 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ:ASTH), a leading provider-centric, technology-powered healthcare company enabling providers to deliver accessible, high-quality, and high-value care to all, today announced its consolidated financial results for the fourth quarter and year ended December 31, 2024. "Astrana Health's strong performance in 2024 highlights the s

      2/27/25 4:27:00 PM ET
      $ASTH
      Professional Services
      Consumer Discretionary

    $ASTH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Barclays initiated coverage on Astrana Health with a new price target

      Barclays initiated coverage of Astrana Health with a rating of Equal Weight and set a new price target of $36.00

      4/1/25 7:41:49 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • TD Cowen initiated coverage on Astrana Health with a new price target

      TD Cowen initiated coverage of Astrana Health with a rating of Buy and set a new price target of $66.00

      10/14/24 7:24:49 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary
    • KeyBanc Capital Markets initiated coverage on Astrana Health

      KeyBanc Capital Markets initiated coverage of Astrana Health with a rating of Sector Weight

      10/11/24 7:36:28 AM ET
      $ASTH
      Professional Services
      Consumer Discretionary